Orchard Capital Managment, LLC Akebia Therapeutics, Inc. Transaction History
Orchard Capital Managment, LLC
- $111 Million
- Q3 2025
A detailed history of Orchard Capital Managment, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Orchard Capital Managment, LLC holds 53,510 shares of AKBA stock, worth $90,967. This represents 0.13% of its overall portfolio holdings.
Number of Shares
53,510
Previous 53,510
-0.0%
Holding current value
$90,967
Previous $194,000
25.77%
% of portfolio
0.13%
Previous 0.22%
Shares
12 transactions
Others Institutions Holding AKBA
# of Institutions
191Shares Held
122MCall Options Held
267KPut Options Held
280K-
Vanguard Group Inc Valley Forge, PA15.5MShares$26.4 Million0.0% of portfolio
-
State Street Corp Boston, MA11.8MShares$20.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$19.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.18MShares$10.5 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$9.77 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $313M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...